Eating very little on Mounjaro but the scales aren't moving? Here's what's likely happening

The scale measures more than fat, and that's the root of the confusion

When people ask this question, they're usually weighing themselves daily and seeing a number that isn't falling despite eating far less than before. The frustration is completely understandable. But body weight at any given moment reflects water, glycogen, undigested food, muscle tissue and fat all at once. Mounjaro (tirzepatide) works by activating both GIP and GLP-1 receptors, which slows gastric emptying and reduces appetite significantly. That means food stays in your digestive tract longer. So even if you're consuming much less, there may be more undigested food present at any point in the day than you'd expect.

Fluid shifts complicate things further. When you first reduce calorie intake sharply, the body releases stored glycogen, which carries water with it, that's often the fast early drop people see. Once that phase passes, fat loss continues more slowly, and the scale can look flat even though fat is still being lost. If you've noticed your clothes fitting differently while the number holds steady, that's not an illusion. It's a real phenomenon documented in weight-management research.

For a thorough explanation of why the scale can stall even when tirzepatide is working as expected, the detailed breakdown of Mounjaro and stalled weight loss covers the mechanisms in more depth.

Very low food intake can work against fat loss, not just for it

This is the part that surprises most people. Eating very little sounds like the fastest route to weight loss, but chronically low intake (particularly low protein) tells the body to protect itself. It does that partly by burning muscle rather than fat, and partly by reducing overall metabolic rate. Neither outcome shows up as dramatic scale loss; they show up as a flattening curve and a body that's getting softer rather than leaner.

On Mounjaro, appetite suppression can be powerful enough that some people eat far below what they need in terms of protein and total nutrition. The NHS guidance on weight-management injections specifically notes that adequate nutrition remains important alongside treatment. Hitting a protein target (roughly 1.2–1.6 g per kg of body weight, though your prescriber is the right person to set that for you) helps preserve muscle while fat is lost. So does resistance exercise, even light bodyweight work.

If you're eating almost nothing and the scale isn't moving, the answer is often not to eat even less. It may be the opposite. A prescriber or dietitian can help you find the intake level that supports fat loss without triggering the conservation response. The broader question of why some people don't lose weight on Mounjaro explores this and other contributing factors.

Timing: how long this medicine actually takes to produce measurable results

Treatment starts at 2.5 mg, which is a dose chosen for tolerability. It's the body's adjustment period, not the point at which significant weight loss is expected. Meaningful progress for many people begins at higher doses, typically from 5 mg onwards, and the SURMOUNT-1 trial (which involved over 2,500 adults and ran for 72 weeks) showed that the greatest weight reductions accumulated over many months, not weeks. Average weight reduction at the highest dose reached around 20–21% across the trial period, but that did not happen in a linear, predictable way week by week.

A stall of two to four weeks, even at a higher dose, is within normal variation. If you've recently increased your dose, your body is also adjusting to the change, which can temporarily mask loss. For a realistic picture of the timeline involved, how long Mounjaro takes to work sets out what trial data and clinical experience actually suggest.

It's also worth factoring in things that have nothing to do with the medicine: stress raises cortisol, which promotes fluid retention; disrupted sleep affects hunger hormones independently of GLP-1 pathways; and for people who menstruate, weight can fluctuate by two to four pounds across a cycle without any change in fat mass. Daily weigh-ins amplify all of this. Weekly measurements, taken at the same time of day, give a cleaner signal. The question of what to do when you're barely eating on Mounjaro and still not losing addresses the practical steps to take from here.

When to speak to a prescriber rather than waiting it out

Most short-term plateaus resolve without any change to treatment. But there are situations where a clinical conversation is worth having sooner rather than later. If you've been at your current dose for more than 12 weeks with no change in weight or measurements, if you're eating so little that you feel faint, fatigued or unable to function, or if you're experiencing persistent nausea or other side effects that are limiting your intake beyond what feels sustainable, those are all worth raising with your prescriber.

NICE's appraisal of tirzepatide (NICE TA1026) includes a review point: if less than 5% of body weight has been lost after six months at the highest tolerated dose, continuing treatment should be assessed. That's a clinical threshold, not a reason to panic at week eight, but it underlines that a prescriber should be in the loop on long-term progress. Mounjaro is a dual GIP and GLP-1 receptor agonist with a well-documented clinical profile; if something isn't adding up, that's a conversation for a real clinician, not a forum.

At nume, our prescribers review your case before every repeat order, which means there's a built-in clinical checkpoint to catch exactly this kind of situation. If you haven't started yet and want to understand whether this treatment is right for you, you can start a free consultation and have your answers reviewed the same day by a GPhC-registered prescriber. Wondering about the cost of ongoing treatment? The Mounjaro price comparison lays out what private treatment typically involves in the UK.